Observational study of superinfections in a cohort of COVID-19 patients during inpatient treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031367

Enrollment

997

Registered

2023-03-01

Start date

2020-08-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superinfections in COVID-19

Interventions

Group 1: Adult patients with COVID-19 infection who received inpatient treatment.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - positive COVID-19 PCR - inpatient treatment with COVID-19

Exclusion criteria

Exclusion criteria: - nosocomial infection (for multistate modeling)

Design outcomes

Primary

Measure	Time frame
Frequency and type of bacterial and/or fungal co-infections and superinfections in COVID-19 patients in the period from hospital admission to discharge.	—

Secondary

Measure	Time frame
Relationship between co-/superinfections and age, gender, duration of hospital stay or intensive care treatment in COVID-19 patients.	—

Countries

Germany

Contacts

Public ContactAnne Lösslein

Institut für Medizinische Mikrobiologie

anne.loesslein@uniklinik-freiburg.de07612036539

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026